--- title: "How Much Does Tirzepatide Cost in 2026?" description: "Tirzepatide is sold in different products and payment programs. Compare Mounjaro, Zepbound and any compounded prescription separately, including dose, supply length, eligibility and the total you pay." summary: "Tirzepatide is sold in different products and payment programs. Compare Mounjaro, Zepbound and any compounded prescription separately, including dose, supply length, eligibility and the total you pay." canonical: https://remevihealth.com/blog/how-much-does-tirzepatide-cost/ language: en publisher: REMEVi author: "REMEVi Medical Team" medicalReviewer: "Linda West-Conforti, RN" reviewStatus: current reviewedDate: 2026-09-22T00:00:00.000Z pubDate: 2026-07-07T00:00:00.000Z updatedDate: 2026-09-16T00:00:00.000Z tags: ["tirzepatide cost","how much does tirzepatide cost","tirzepatide price","tirzepatide cost without insurance"] alternateLanguage: https://remevihealth.com/es/blog/cuanto-cuesta-tirzepatida/ license: "© 2026 REMEVi LLC. Please cite https://remevihealth.com/blog/how-much-does-tirzepatide-cost/ as the source." --- ## Short answer Tirzepatide is sold in different products and payment programs. Compare Mounjaro, Zepbound and any compounded prescription separately, including dose, supply length, eligibility and the total you pay. **Medically reviewed by** [Linda West-Conforti, RN](/medical-team/) · [CA RN #389453](https://search.dca.ca.gov/details/4500/RN/389453/) · 2026-09-22. Founding Nurse · Patient Care Lead. Tirzepatide is sold in different products and payment programs. Compare Mounjaro, Zepbound and any compounded prescription separately, including dose, supply length, eligibility and the total you pay. ## Ozempic injection: verified self-pay pricing As checked **September 14, 2026**, Novo Nordisk advertises $199 for each of the first two monthly fills of the 0.25 or 0.5 mg starting doses for eligible new patients, with fills through December 31, 2026. Ongoing prices are **$349** for 0.25, 0.5 or 1 mg and **$499** for 2 mg. The manufacturer defines a month as one box containing one pen. Eligibility and changeable terms apply; this is not a price promise for every prescription. [Source: Ozempic manufacturer savings terms](https://www.ozempic.com/savings-and-resources/save-on-ozempic.html) ## Wegovy: identify the formulation As checked **September 14, 2026**, manufacturer offers distinguish tablets from pens. For the 0.25 through 2.4 mg pens, the advertised ongoing price is **$349 per box of four pens** after any applicable introductory offer; the 7.2 mg HD pen has a separate price. Tablets have dose-specific prices and terms. Confirm the maintenance cost, not only the first fill. [Source: Wegovy manufacturer savings terms](https://www.wegovy.com/obesity/what-to-pay-for-wegovy.html) ## Mounjaro and Zepbound have different programs Mounjaro is indicated for type 2 diabetes; Zepbound has its own indications including weight management. Zepbound self-pay offers advertise a starting price of **$299 for a four-week supply of 2.5 mg** in a KwikPen or vials; this is a starting dose, not maintenance. Later costs depend on dose, device and refill terms. That offer does not establish a Mounjaro price. Check each manufacturer’s information, reviewed **September 14, 2026**. [Source: Zepbound manufacturer savings terms](https://zepbound.lilly.com/savings) [Source: Mounjaro manufacturer cost information](https://pricinginfo.lilly.com/mounjaro) ## What insurance changes Coverage depends on the drug, diagnosis, plan formulary and prior authorization. Ask about the cost after your deductible and any required clinical documentation. Commercial savings and self-pay offers have different rules. Medicare GLP-1 Bridge is a temporary program for certain eligible beneficiaries beginning in July 2026; it does not mean automatic coverage for everyone. [CMS: Medicare GLP-1 Bridge eligibility](https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge) ## REMEVi plans: billing period and total payment REMEVi prices use **four-week billing periods**, which are not calendar months. The 12- and 24-week terms require the full total upfront. Lab work that the clinician requires for treatment is included. | Compounded preparation | Every 4 weeks | 12 weeks: total upfront | 24 weeks: total upfront | |---|---:|---:|---:| | Injectable semaglutide | $199 | $507 ($169/4 weeks) | $954 ($159/4 weeks) | | Injectable tirzepatide | $269 | $699 ($233/4 weeks) | $1,350 ($225/4 weeks) | | Compounded oral semaglutide | $249 | $687 ($229/4 weeks) | $1,290 ($215/4 weeks) | See current [semaglutide](/semaglutide/) and [tirzepatide](/tirzepatide/) plan details. Compounded oral semaglutide is not an approved Wegovy, Ozempic or Rybelsus tablet. Eligibility and prescribing depend on clinical evaluation. Service is available in 49 states and Washington, DC, excluding Louisiana. ## The product distinction matters Compounded preparations are not FDA-approved, are not generics of the brands and do not have established clinical equivalence to them. FDA recommends their use only when an available approved product cannot meet the medical need. A lower price does not establish equal safety or effectiveness. [Source: FDA: unapproved GLP-1 medicines](https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss) ## Before choosing Confirm the product, route, pharmacy, supply length, full upfront payment, refill terms and cancellation policy. Ask who handles side effects and what happens if clinical review does not recommend treatment. [Review care options](/semaglutide/). ## Frequently asked questions ### Is the starting price the maintenance cost? Not necessarily. Confirm dose, supply period, eligibility and ongoing price; manufacturer offers can change. ### Are REMEVi plans billed by calendar month? No. Prices use four-week periods. The 12- and 24-week plans require the full total upfront; clinician-required labs are included. ## Sources linked in this article These are the external references linked in the article. A reference supports the statement where it appears; it is not an endorsement of REMEVi or a substitute for individual medical advice. - [Source: Ozempic manufacturer savings terms](https://www.ozempic.com/savings-and-resources/save-on-ozempic.html) - [Source: Wegovy manufacturer savings terms](https://www.wegovy.com/obesity/what-to-pay-for-wegovy.html) - [Source: Zepbound manufacturer savings terms](https://zepbound.lilly.com/savings) - [Source: Mounjaro manufacturer cost information](https://pricinginfo.lilly.com/mounjaro) - [CMS: Medicare GLP-1 Bridge eligibility](https://www.cms.gov/medicare/coverage/prescription-drug-coverage/medicare-glp-1-bridge) - [Source: FDA: unapproved GLP-1 medicines](https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss) ## Related reading - [How Much Does Mounjaro Cost?](/blog/how-much-does-mounjaro-cost/) - [How Much Does Zepbound Cost?](/blog/how-much-does-zepbound-cost/) - [Semaglutide vs. Tirzepatide: Differences, Results and Costs](/blog/semaglutide-vs-tirzepatide/) ## About this article Published by REMEVi, a telehealth business offering paid treatment programs. REMEVi has a commercial interest in the services discussed here. Educational content supports informed conversations with a licensed clinician; it does not determine your eligibility or replace individual care.